1 WHO/HSE/GCR/LYO/ Laboratory Assessment Tool Annex 1: Laboratory Assessment Tool / System Questionnaire April 2012 World Health Organization 2012 All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.
2 Table of content General 1 Coordination and management 2 Structure and organization 8 Regulations 13 Quality of laboratory system 16 Laboratory management 24 Infrastructure 26 Human resources 27 Biorisk management 32 Gap analysis 36 Summary 39 Acronyms 40
3 Annex 1: LAT/System - General 1 General Country assessed Date of the assessment (DD/MM/YYYY) Name and contact details of the assessor List name/s, contact details and level/s of authority of key interviewed person/s Comments
4 Annex 1: LAT/System - Coordination and management 2 1. Coordination and management Possible answers (unless otherwise advised): 1.Yes; 2.Partial; 3.No; 4.Non applicable Coordination 1.1 Does the relevant Ministry have a dedicated unit in charge of health laboratory coordination? 1.2 If yes, please provide name/s, terms of reference and contact details of the unit and responsible person/s X 1.3 Is there an official decree/text establishing the health laboratory coordination unit and defining terms of reference? X 1.4 Has this unit a dedicated budget? 1.5 Has this unit developed coordination mechanisms with disease-specific control programmes? 1.6 Has this unit an oversight role of reference laboratory designation and operations? 1.7 Does this unit participate in public health-related committees such as influenza preparedness committees, emergency committees, or immunization committees? 1.8 Does the coordinating unit coordinate its activities with the Ministry of Agriculture or its relevant agencies?
5 Annex 1: LAT/System - Coordination and management Do the coordinating unit coordinate their activities with the Ministry of Environment or its relevant agencies? 1.10 Does the coordinating unit coordinate its activities with the Ministry of Education about laboratory worker education? 1.11 Has this unit an oversight role of private laboratory regulations and operations? 1.12 Is the unit assisted by an advisory body (committee or commission)? 1.13 If yes, please provide terms of reference and composition of the body X 1.14 Is there a national policy for health laboratory services defining the goals and objectives of the national laboratory system? X If yes or partial, does the policy address: 1.15 Laboratory service coordination and leadership? 1.16 Laboratory service structure and organization? 1.17 Laboratory service testing capacity?
6 Annex 1: LAT/System - Coordination and management Laboratory service networking mechanisms? 1.19 Laboratory service role in public health? 1.20 Laboratory service regulatory framework? 1.21 Laboratory service quality assurance framework? 1.22 Laboratory workforce? 1.23 Laboratory equipement and reagent procurement and supplying systems? 1.24 Laboratory service funding? 1.25 Is there a strategic plan aiming at strengthening laboratory services or other strategic plan/s with a laboratory component? X 1.26 If yes or partial, please briefly describe main components of the plan
7 Annex 1: LAT/System - Coordination and management Is the plan funded and implemented? 1.28 Are there indicators to monitor laboratory services (as part of the strategic plan monitoring or separately from the plan)? X 1.29 If yes or partial, please list these indicators Funding How are the laboratory services funded (for each source, specify percentage of funding)? 1.30 Government or public health insurance 1.31 User's fees 1.32 Donors 1.33 Other (specify)
8 Annex 1: LAT/System - Coordination and management Is there a specific budget assigned for public health laboratory activities (such as reference laboratories and networks operations)? 1.35 Has a cost-effectiveness analysis been performed to select technically and financially appropriate laboratory technologies and methods? X 1.36 Are testing prices regulated? If yes, are testing prices recommended by: 1.37 A national regulation/legislation? 1.38 Public health insurance system (social security)? 1.39 Private health insurance system? Equipment and supply management 1.40 Please describe the procurement system/s for public laboratories (centralized or decentralized purchasing and storage, bulk or small purchasing, quality of supplies, suppliers' location, etc.) and provide all necessary documents X
9 Annex 1: LAT/System - Coordination and management Please describe the procurement system/s for private laboratories (centralized or decentralized purchasing and storage, bulk or small purchasing, quality of supplies, suppliers' location, etc.) and provide all necessary documents X 1.42 Do disease-specific control programmes (e.g. TB, malaria) use specific procurement systems? 1.43 Are there national guidelines on laboratory equipment donations? 1.44 Are coordination mechanisms established with donors for equipment and supply donation or procurement? 1.45 Do the donors or partners (e.g. NGOs, international organizations, foundations) follow national regulations for equipment or supply procurement (e.g. distribution of qualified IVD devices only)? Comments
10 Annex 1: LAT/System - Structure and organization 8 2. Structure and organization Possible answers (unless otherwise advised): 1.Yes; 2.Partial; 3.No; 4.Non applicable Structure 2.1 Is organizational structure of the laboratory services clearly defined with lines of authority? 2.2 If yes, please provide and comment any related charts or documents X 2.3 Are the laboratories organized in a tiered system with different levels of functions? 2.4 Is there an inventory or directory of laboratories performing clinical testing (health centre, hospital, public health, academic, research, etc.) in the country? X 2.5 Does this inventory take into account private clinical laboratories? 2.6 What kind of is recorded for each laboratory (contact details, testing capacity, staff number, etc.)?
11 Annex 1: LAT/System - Structure and organization 9 Please estimate the number of laboratories within the following definitions: 2.7 Central/national/reference laboratories 2.8 Intermediate laboratories (regional or provincial level) 2.9 Peripheral laboratories (district or health centre level) Reference laboratories 2.10 Are reference laboratories identified for priority diseases or public health threats? 2.11 If yes or partial, please provide the list of reference laboratories (e.g. TB, HIV) X 2.12 Are these reference laboratories officially designated (e.g. by directive, by regulation, by national authorities)? X 2.13 Are reference laboratories part of a national early warning system in place for public health events/outbreaks?
12 Annex 1: LAT/System - Structure and organization Do representatives from reference laboratories routinely participate in outbreak or public health event preparedness and management meetings? 2.15 Do representatives from reference laboratories routinely participate in field investigations during public health events (e.g. outbreaks)? Networking mechanisms 2.16 Are laboratories organized in network/s for clinical testing purposes (e.g. access to specialized or confirmatory testing that is not available at the patient location)? 2.17 If yes or partial, please describe for each network: member laboratory names or types, networking mechanisms (especially how samples and data are shared across the networks), documentation developed (SOPs, testing algorithm, reports forms) and funding sources 2.18 Are laboratories organized in networks for public health or surveillance purposes? 2.19 If yes or partial, please describe for each network: member laboratory names or types, networking mechanisms (especially how samples and data are shared across the networks), documentation developed (SOPs, testing algorithm, reports forms) and funding sources
13 Annex 1: LAT/System - Structure and organization Are private laboratories part of the surveillance network/s? 2.21 If yes, is participation of private laboratories mandatory, imposed by law, through contractual agreement, etc.? 2.22 Are these network/s officially designated (e.g. by directive, by regulation, by national authorities)? 2.23 Are reference laboratories members of international networks? 2.24 If yes or partial, please provide the list of laboratories and networks 2.25 Are there standardized reporting form/s for laboratory data within and across network/s? X 2.26 Is there a stock of emergency sample collection and transport supplies (personal protective equipment, sample collection material, transport media)?
14 Annex 1: LAT/System - Structure and organization 12 If yes, where are they positioned/stored? 2.27 Central/reference level 2.28 Intermediate level 2.29 Peripheral level Comments
15 Annex 1: LAT/System - Regulations Regulations Possible answers (unless otherwise advised): 1.Yes; 2.Partial; 3.No; 4.Non applicable 3.1 Do public laboratories need to be registered or licensed to operate? 3.2 Do private laboratories need to be registered or licensed to operate? 3.3 Please describe any registration and/or licensing criteria X 3.4 If applicable, is the license/work authorization delivered after an initial on-site visit? 3.5 If applicable, is the license/work authorization periodically reviewed? 3.6 How is the compliance with licensing criteria ensured (describe any inspection or control mechanism)?
16 Annex 1: LAT/System - Regulations 14 Are the following areas regulated (as part of licensing mechanism or separately): 3.7 Laboratory facilities? 3.8 Equipment? 3.9 Staff? 3.10 In vitro diagnostic medical device qualification? 3.11 Sample transportation? 3.12 Testing methods? 3.13 Data management? 3.14 Biorisk management measures?
17 Annex 1: LAT/System - Regulations Laboratory related ethics? 3.16 Are legislation and regulations regularly evaluated and updated to maintain relevance for evolving national and international needs? Comments
18 Annex 1: LAT/System - Quality of laboratory system Quality of laboratory system Possible answers (unless otherwise advised): 1.Yes; 2.Partial; 3.No; 4.Non applicable National standardization 4.1 Is there a national laboratory quality office for oversight of national laboratory quality programmes? X 4.2 If yes, name and contact details of the office/responsible person/s 4.3 Please briefly describe the national quality programme/s in place 4.4 Are national general quality norms/sets of standards established? X If yes or partial, do they address these topics: 4.5 Laboratory organization and management? 4.6 Documentation and records?
19 Annex 1: LAT/System - Quality of laboratory system Specimen collection and transport? 4.8 SOPs for specimen processing? 4.9 Personnel and education requirements? 4.10 Biorisk management? 4.11 Equipment, reagents, reference materials, consumables management? 4.12 Collaboration with referral laboratories? 4.13 Internal quality control procedures? 4.14 External quality assessment procedures? 4.15 Data and management?
20 Annex 1: LAT/System - Quality of laboratory system Are more specific quality standards available through membership of defined networks (e.g. TB, HIV)? In case laboratory services are organized in tiered network: 4.17 Are minimal equipments standardized for each laboratory level? X 4.18 Are minimal staff number and qualifications standardized for each laboratory level? X 4.19 Are tests performed and methods standardized for each laboratory level? X 4.20 Please describe how and by whom norms and standards are developed (e.g. by standardization body, professional societies, specialized networks, reference laboratories) Quality assessment 4.21 Is there a national body in charge of laboratory inspection?
21 Annex 1: LAT/System - Quality of laboratory system If yes, please describe the inspection mechanism (frequency, procedures, sanctions, etc.) 4.23 Is there a national body in charge of laboratory certification (e.g. using ISO 9001)? 4.24 If yes, please provide name/s: 4.25 Is there a national body in charge of laboratory accreditation (e.g. using ISO 15189)? 4.26 If yes, please provide name/s: 4.27 If no, do laboratories use services of foreign national or regional accreditation bodies? 4.28 If yes, please provide name/s: 4.29 Are some laboratories accredited for disease-specific testing by WHO (e.g. polio, measles, HIV genotyping)?
22 Annex 1: LAT/System - Quality of laboratory system Please provide number of laboratories certified or accredited and specify to which standard 4.31 Is there a specific national document which describes the registration procedure for in vitro diagnostic medical devices (IVD, i.e. kits and reagents)? X 4.32 Is there a national regulatory authority responsible for in vitro diagnostic device (e.g. reagents) qualification or registration? 4.33 If yes, please provide a summary of the qualification or registration mechanisms X 4.34 Besides the inspection, certification or accreditation detailed above is any other kind of supervision organized? 4.35 If yes or partial, describe the supervision plan and procedures (e.g. through specific networks like TB control programme or surveillance programmes) X 4.36 Are there standardized supervision checklists or procedures? X 4.37 When supervised, do the laboratories receive a report after each supervision? X
23 Annex 1: LAT/System - Quality of laboratory system Are there indicators to measure the progress in laboratory test quality? 4.39 Please list these indicators Does your country have a national EQA programme (proficiency-testing or rechecking) in the following areas: 4.40 Bacteriology? 4.41 Virology? 4.42 Serology? 4.43 Parasitology? 4.44 Biochemistry
24 Annex 1: LAT/System - Quality of laboratory system Haematology? 4.46 Anatomical pathology? 4.47 Cytogenetic? 4.48 Transfusion medicine? 4.49 Please describe the national EQA programme/s organization by providing for each: name of the programme, contact person/s, one line of description 4.50 If applicable, is participation in national EQA programmes/s mandatory for public laboratories? 4.51 If applicable, is participation in national EQA programmes/s mandatory for private laboratories? 4.52 Percentage of public laboratories participating in the national EQA scheme (EQAS):
25 Annex 1: LAT/System - Quality of laboratory system Percentage of private laboratories participating in the national EQAS: 4.54 Are corrective actions organized when assessment result is poor? X Comments
26 Annex 1: LAT/System - Laboratory management Laboratory management Possible answers (unless otherwise advised): 1.Yes; 2.Partial; 3.No; 4.Non applicable 5.1 Does the MoH laboratory coordination unit collect any laboratory data? 5.2 If yes or partial, please describe which kind of data (tests ordered and/or performed, logistics data, scientific data, etc.) and data collection mechanisms X 5.3 Are standardized forms available to collect these data? X 5.4 Does the MoH use a computerized Laboratory Information System (LIS) to collect and analyse data? 5.5 Is this LIS connected to the MoH Health Information System? X 5.6 If yes, describe how 5.7 Does the MoH laboratory coordination unit share data with other agencies or units?
27 Annex 1: LAT/System - Laboratory management If yes or partial, please describe which data and for which purpose 5.9 Does the MoH laboratory coordination unit ensure feedback to the laboratory community? 5.10 If yes, please describe the communication mechanisms and procedures (e.g. newsletter, website) Comments
28 Annex 1: LAT/System - Infrastructure Infrastructure Possible answers (unless otherwise advised): 1.Yes; 2.Partial; 3.No; 4.Non applicable 6.1 Are there any requirements in terms of building and facilities for laboratory operations (e.g. cold storage, containment requirements)? 6.2 Is the facility infrastructure generally satisfactory throughout the country (i.e. ensuring quality of work and safety of staff)? 6.3 Is there any national plan or project to build, renovate or upgrade laboratory facilities? 6.4 If yes, describe laboratory concerned, objectives and funding sources Comments
29 Annex 1: LAT/System - Human resources Human resources Possible answers (unless otherwise advised): 1.Yes; 2.Partial; 3.No; 4.Non applicable Staff 7.1 Is there an inventory of laboratory workers? X 7.2 Is the overall number of laboratory workers sufficient for the healthcare needs? 7.3 Is the laboratory staff well distributed within the country in accordance with the needs? 7.4 Is the education/training/experience of laboratory workers in accordance with the needs of the work? 7.5 Is the salary of laboratory workers appropriate for the work? 7.6 Are most laboratory workers national staff (as compared with workers from other countries)? 7.7 Does the country graduate adequate number of trained personnel for its needs? 7.8 Are there trained biomedical engineers/technicians (for specific laboratory equipment maintenance) inside the country?
30 Annex 1: LAT/System - Human resources Is qualified staff easily maintained in laboratory in the country? 7.10 If no, please list the difficulties 7.11 Is the licensing/registration of laboratory workers organized? X 7.12 If yes, please describe the licensing/registration requirements 7.13 How many people are licensed/registered as laboratory workers? 7.14 If applicable, is continuous education/training mandatory to renew staff work authorization? Education Are national specific degrees delivered for: 7.15 Laboratory technicians? 7.16 Post-graduate clinical pathologists?
31 Annex 1: LAT/System - Human resources Post-graduate medical microbiologists? 7.18 If yes, please provide name/s of these degree/s and associated curricula: 7.19 Are these degrees mandatory for working in a medical laboratory? 7.20 Are there interministerial mechanisms involving health and education ministries to review and adapt training curricula according to the needs? X 7.21 Do laboratory workers have access to suitable continuous education/training? Is continuous education available in the following areas: 7.22 Specimen collection, packaging and transportation? 7.23 Laboratory quality assurance? 7.24 New laboratory diagnostic techniques?
32 Annex 1: LAT/System - Human resources Data management? 7.26 Epidemiological surveillance? 7.27 Field Epidemiology and Laboratory Training Programme? 7.28 Computer science applied to laboratory? 7.29 Biorisk management? 7.30 Laboratory management? 7.31 How are these courses provided (manufacturing companies, professional societies, distance learning, face-to-face, etc.)?
33 Annex 1: LAT/System - Human resources 31 Comments
34 Annex 1: LAT/System - Biorisk management Biorisk management Possible answers (unless otherwise advised): 1.Yes; 2.Partial; 3.No; 4.Non applicable 8.1 Does the relevant ministry have a dedicated unit in charge of biosafety/biosecurity at national level? 8.2 If yes, name and contact details of the unit/responsible person/s X 8.3 Have biological risks and pathogens been identified, classified and listed at the national level? X 8.4 Does a national up-to-date legislation define minimal biosafety levels, measures or requirements for operation? 8.5 If yes, please describe them shortly and provide relevant documentation X 8.6 Are specific policy or regulation for waste management and disposal available?
35 Annex 1: LAT/System - Biorisk management If yes, please describe them shortly and provide relevant documentation X 8.8 Are inspections of laboratories performed by national authorities to evaluate compliance with biosafety requirement? 8.9 Does the country have functional BSL-3 laboratories to deal with highly dangerous pathogens? 8.10 If yes, number of functional BSL-3 laboratories: 8.11 Please also provide the number of functional BSL-4 laboratories: 8.12 Are the new facilities formally commisioned before opening? 8.13 Can the biosafety cabinets (BSC) be certified by local certification bodies?
36 Annex 1: LAT/System - Biorisk management Is there a specific national document for specimen packaging and transportation? X 8.15 If yes, is its application mandatory by law or decree? 8.16 Are specific packages (like triple packages complying with P620 and P650 requirements) available? 8.17 If yes, from which source/s? Local suppliers, foreign suppliers, external assistance (e.g. NGO, UN) 8.18 Are national regulations in place and up-to-date for the transport of infectious substances (Categories A and B)? X 8.19 Do local carriers ensure the transport of infectious substances according to the national requirements? 8.20 Are infectious substances (Categories A and B) imported or exported from/to other countries? 8.21 Do central/reference laboratories have access to express courier service/s (e.g. DHL, FedEx, World Courier)? 8.22 Do the people responsible for the shipment of specimens have access to training on infectious substance transport?
37 Annex 1: LAT/System - Biorisk management If yes, are these trainings in line with United Nations regulations on the transport of infectious substances? 8.24 Do laboratory staff have access to occupational/worker health services in all facilities? 8.25 Is there a specific vaccination policy (pre-exposure prophylaxis) for laboratory workers (Hepatitis B and other relevant diseases)? X 8.26 Are vaccines that have been identified as mandatory provided to laboratory workers? 8.27 Is post-exposure prophylaxis treatment provided to laboratory workers in all facilities? Comments
38 Annex 1: LAT/System - Gap analysis Gap analysis What are the biggest needs/weaknesses of the national laboratory system? Score from 0 (no gap) to 5 (high gap) for the items below and please provide comments for the area/s that display the biggest weaknesses (scores 4 and 5) 0; ; 5 Comments 9.1 Financial resources for laboratory activities 9.2 Human resources qualifications and availability of suitable laboratory staff 9.3 Equipment adequacy 9.4 Reagent and consumable quality 9.5 National guidelines on specific laboratory practices 9.6 Collection of specimens 9.7 Transportation of specimens
39 Annex 1: LAT/System - Gap analysis Laboratory organization, service delivery structure, and networking 9.9 Regulatory framework 9.10 Laboratory safety or security 9.11 Quality assurance 9.12 Recognition of importance of laboratory services 9.13 Political commitment (national laboratory policies, budget, etc.) 9.14 Other For other, please specify:
40 Annex 1: LAT/System - Gap analysis 38 Comments
41 Annex 1: LAT/System - Summary 39 Laboratory System Assessment Questionnaire Report General comments on the assessment Conclusions and recommendations
42 Annex 1: LAT/System - Acronyms 40 Acronyms referred to in this document BSC BSL EQA EQAS HIV HR ISO IVD LIS MoH NGO SOP TB UN WHO Biosafety Cabinet Biosafety Level External Quality Assessment External Quality Assessment Scheme Human Immunodeficiency Virus Human Resources International Organization for Standardization In vitro diagnostic medical devices Laboratory Information System Ministry of Health Non-Governmental Organization Standard Operating Procedure/s Tuberculosis United Nations World Health Organization
Laboratory accreditation WHO global perspective Sébastien Cognat WHO Lyo on office Laboratory Quality and Ma anagement Strengthening IHR coordinatio on department leventh General Program mme of Work 2006-2015
ENIVD CODE OF CONDUCT for Outbreak Assistance Laboratories CHECKLIST of major issues to address before departure and during the mission This document has been designed for ECDC and ENIVD-CLRN network members
Summary report on the Regional meeting of directors of national blood transfusion services WHO-EM/LAB/386/E Tunis, Tunisia 17 19 May 2016 Summary report on the Regional meeting of directors of national
RESTRICTED September 2006 PREQUALIFICATION OF QUALITY CONTROL LABORATORIES Procedure for assessing the acceptability, in principle, of quality control laboratories for use by United Nations agencies The
DISEASE SURVEILLANCE AND RESPONSE PROGRAMME AREA DISEASE PREVENTION AND CONTROL CLUSTER LABORATORY CAPACITY REQUIREMENTS FOR INTERNATIONAL HEALTH REGULATIONS AND THEIR IMPLEMENTATION IN THE WHO AFRICAN
REPOSITIONING OUR CLINICAL LABORATORIES FOR EFFECTIVE AND EFFICIENT HEALTHCARE DELIVERY. By Prof. Ibironke Akinsete Chairman PathCare Nigeria Overview of Clinical Laboratories The duties of clinical laboratories
2014 APHL All Hazards Laboratory Preparedness Survey 2017 APHL BIOSAFETY AND BIOSECURITY SURVEY SUMMARY DATA REPORT April 2018 Introduction The 2017 APHL Biosafety and Biosecurity Survey was launched on
Strategy of TB laboratories for TB Control Program in Developing Countries Borann SAR, MD, PhD, Institut Pasteur du Cambodge Phnom Penh, Cambodia TB Control Program Structure of TB Control Establish the
STANDARDS Point-of-Care Testing For Surveys Starting After: January 1, 2018 Date Generated: January 12, 2017 Point-of-Care Testing Published by Accreditation Canada. All rights reserved. No part of this
DTRA/Cooperative Biological Engagement Program Evaluation of Impact of CBEP Training Activities on the Performance of Targeted Laboratories in Iraq JANUARY 2016 Developed by University Research Co., LLC
Joint external evaluation of IHR Core Capacities of the Republic of Uganda Executive summary June 26-30, 2017 WHO/WHE/CPI/SUM/2017.39 World Health Organization 2017 Some rights reserved. This work is available
Review of the commitments of WHO European Member States and the WHO Regional Office for Europe between 1990 and 2010 Analysis in the light of the Health 2020 strategy By Roberto Bertollini, Celine Brassart
Biological Weapons Convention Meeting of Experts Geneva, Switzerland 18-22 August 2008 WHO's Biosafety and Laboratory Biosecurity Dr Nicoletta Previsani Biosafety and Laboratory Biosecurity Biorisk Reduction
Advancing Biosafety Across the U.S. Clinical Laboratory Community Reynolds M Salerno, PhD Director, Division of Laboratory Systems June 5, 2018 Excellent Laboratories, 1 Outstanding Health 2014 A four-year-old
Summary report on the Regional consultation on the availability and safety of blood transfusion during humanitarian emergencies WHO-EM/LAB/387/E Tunis, Tunisia 15 16 May 2016 Summary report on the Regional
Standards for Laboratory Accreditation 2017 Edition cap.org 2017 College of American Pathologists. All rights reserved. [ T y p e t h e c o m p a n y a d d r e s s ] CAP Laboratory Accreditation Program
XIII. TRAINING A multitude of training requirements are addressed by OSHA and other safety, health and environmental regulations. A summary of these requirements are presented. A. Hazard Communication/Right-to-Know
WHO-EM/NUR/429/E Strengthening nursing and midwifery in the Eastern Mediterranean Region A framework for action 2016-2025 Strengthening nursing and midwifery in the Eastern Mediterranean Region A framework
World Association of Veterinary Laboratory Diagnosticians 14th International Symposium Madrid, Spain 17-20 June 2009 The WHO laboratory network to enhance laboratory biosafety and biosecurity in developing
GLOBAL HEALTH SECURITY AGENDA ROADMAP FOR ETHIOPIA March 9, 2016 Last updated 9 March 2016 1 Overview and Context The purpose of this document is to develop a roadmap for ongoing and planned Global Health
UNITED NATIONS DEVELOPMENT PROGRAMME AUDIT OF UNDP BOSNIA AND HERZEGOVINA GRANTS FROM THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA Report No. 1130 Issue Date: 15 January 2014 Table of Contents
Assuring Laboratory Biosecurity Presentation to The Working Group (WG) on Strengthening the Biosecurity of the United States, Established by Executive Order (EO) 13486, January 9, 2009 Ronald Atlas and
Informal note on the draft outline of the report of WHO on progress achieved in realizing the commitments made in the UN Political Declaration on NCDs (NOT AN OFFICIAL DOCUMENT OR FORMAL RECORD 1 ) Geneva,
Examples of Setting Indicators for Each Development Strategic Objective Grant Aid Projects/Standard Indicator Reference (Health) Sector Development strategic objectives (*) Mid-term objectives Sub-targets
BIOSECURITY IN THE LABORATORY Maureen Sullivan Biosecurity Why is biosecurity important History of biosecurity field Definitions Laboratory Biosafety verses Biosecurity Principles and Practice Concepts
SOP WP6-QUAL-04, Version 1.0, 23 February 2014 Page 1 of 8 SOP Title: Laboratory (GCLP) supervision visits Project/study: NIDIAG: this SOP applies to all NIDIAG clinical studies (WP2). 1. Scope and application
Joint External Evaluation of IHR Core Capacities of the Democratic Socialist Republic of Sri Lanka Mission report: June 19-23, 2017 Joint External Evaluation of IHR Core Capacities of the Democratic Socialist
9/16/2014 Purpose VIRGINIA TECH INSTITUTIONAL BIOSAFETY COMMITTEE Ensure the safe and compliant use of biohazardous materials by the university community which includes: o recombinant and synthetic nucleic
Specific Standards of Accreditation for Residency Programs in Adult Infectious Diseases 2016 VERSION 2.0 INTRODUCTION A university wishing to have an accredited program in adult Infectious Diseases must
November 2003. Draft for comments by Member States ESSENTIAL HEALTH TECHNOLOGIES Taking basic health solutions to countries STRATEGY 2004-2007 A needs-driven programme increasingly based on country-prepared
Chapter 7 Conclusion: what works? Fishermen (Abdel Inoua) 7. Conclusion: what works? It is a convenient untruth that there has been no progress in health in the Region. This report has used a wide range
The African Partnerships for Patient Safety Framework Improving Patient Safety: First Steps This resource outlines an approach to improving patient safety using a partnership model, structured around 12
Regulatory,Quality & Emergency Preparedness MaryBeth Parache Director, Quality Affairs New York Blood Center 1 Regulatory 2 Who regulates us? Food and Drug Administration (FDA) Blood, tissue, HCT/P, medical
International Policy Applied Biosafety, 12(1) pp. 9-4 ABSA 2007 Biological Agents and Toxins Act: Development and Enforcement of Biosafety and Biosecurity in Singapore Tin Tun, Kristen E. Sadler, and James
Accreditation of Clinical Laboratories Symposium on Traceability in Laboratory Medicine 9-11 June 2002 BIPM, Sèvres, France Alan Squirrell, ILAC Executive Regina Robertson, NATA, Australia Sean Peters,
NLTC-9 Supporting Your Sentinel Laboratories Rob Nickla, BT/CT LRN Coordinator, STC, RO Oregon State Public Health Laboratory Outline Communication & Relationships State Specifics Sentinel Laboratory Site
Summary report on the Planning meeting to set up a diploma in mental health, human rights and law at the International Islamic University, Islamabad, Pakistan WHO-EM/MNH/208/E Cairo, Egypt 24 26 September
Establishing a Public Health Laboratory System The Namibian Experience Background Namibia Population: 2,259,000 Size: 825,418 km 2 Estimated prevalence of HIV+ adults : 13% # Public Hospitals: 34 # Public
NATIONAL CENTRE FOR ACCREDITATION MEDICAL LABORATORIES - REQUIREMENTS FOR ACCREDITATION ACCORDING TO SM SR EN ISO 15189:2014 Code:DR-LM-03 Edition 4 Page 1/38 Approved by Technical Laboratory Committee
1. Administration and Management (40 Items) A. Quality Assurance (16 items) 1. Determine if technical staff has received training and continuing education 2. Select external laboratory proficiency testing
Institute for Quality Management in Healthcare (IQMH) Toronto, Ontario, Canada Janice Nolan, Executive Director, Programs Thank you! Thank you for inviting me My pleasure to share with you our experience
USAID s Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program (2011-2016) IR* 1: Pharmaceutical sector governance strengthened 1.1 Good governance principles embodied across all health
ACCREDITATION STANDA RDS OCCUPATIONAL HEALTH AND SAFETY The accreditation standards relating to occupational health and safety include those most critical to staff safety in the non-hospital setting; however,
EU/ACP/WHO RENEWED PARTNERSHIP Strengthening pharmaceutical systems and improving access to quality medicines ETHIOPIA 2012 2016 ABOUT THE RENEWED PARTNERSHIP IN ETHIOPIA The Ethiopian segment of the Renewed
IHR Core Capacities Overview and Monitoring Presented by Dr. Samir Refaey Director of Epidemiology and Surveillance Unit Ministry of Health and Population, Egypt Cooperative Agreement for Prevention of
REGIONAL WORKSHOP FOR AFRICA PREPARING FOR THE EIGHTH REVIEW CONFERENCE OF THE BIOLOGICAL WEAPONS CONFERENCE Addis Ababa, Ethiopia, 13 14 September 2016 STRENGTHENING NATIONAL IMPLEMENTATION Austin Ochieng
Version 1.0 9/12/2016 Objectives Part 1: Facility Profile and Scorecard To gather situational analysis information regarding the facility s readiness to provide routine VL monitoring for patients on ART
Reliable laboratory services can be delivered only by specialised facilities that are appropriately constructed and managed to provide the operating environment where the complex interaction of qualified
Annex I Revised forms for the submission of the Confidence-Building Measures At the Third Review Conference it was agreed that all States Parties present the following declaration, later amended by the
National Blood Policy National AIDS Control Organisation Ministry of Health and Family Welfare Government of India New Delhi www.naco.nic.in 2007 Produced and published by National AIDS Control Organisation,
EBOLA- THEN; NOW and FUTURE SIERRA LEONE APHL ANNUAL CONFERENCE 2016 IMPACT Sierra Leone s first cases of Ebola Virus Disease (EVD) occurred in the Eastern region of the country By March 2015, all 14 districts
california legislature 2015 16 regular session ASSEMBLY BILL No. 940 Introduced by Assembly Member Ridley-Thomas February 26, 2015 An act to amend Sections 1209, 1260, 1261.5, 1264, and 1300 of the Business
Appendix 1 Background on some of the pharmaceutical sectors in Kuwait Registration The registration department at Kuwait Drug and Food Control Administration (KDFCA) monitors and supervises all pharmaceuticals,
Prof. Dr. Hasan Abbas Zaheer Project Director Safe Blood Transfusion Services Programme Pakistan Country Introduction BT Sector of Pakistan: Indicators, Facts & Figures System Architecture Key Stakeholders
Tailoring Immunization Programmes (TIP): Outputs of pilot implementation in Bulgaria ABSTRACT The Tailoring Immunization Programmes approach (TIP) aims to help national immunization programmes design targeted
GEN.53400 Section Director (Technical Supervisor) Qualifications/Responsibilities Phase II Section Directors/Technical Supervisors meet defined qualifications and fulfill the expected responsibilities.
GOVERNMENT OF THE REPUBLIC OF SIERRA LEONE MINISTRY OF HEALTH AND SANITATION National Infection Prevention and Control Policy Page 1 of 24 Contents 1 Introduction... 8 1.1 Background... 8 1.2 Healthcare-Associated
Towards Quality Care for Patients National Core Standards for Health Establishments in South Africa Abridged version National Department of Health 2011 National Core Standards for Health Establishments
Iraqi National Journal of Chemistry Journal homepage: http://iqnjc.com/default.aspx Assessment of Awareness Level about Bio Risk Management among Staff of Different Academic Laboratories Sawsan Mohammed
Joint Commission International Accreditation Standards for Hospitals Including Standards for Academic Medical Center Hospitals 6th Edition Effective 1 July 2017 Section I: Accreditation Participation Requirements
Level 5 Diploma in Occupational Health and Safety Practice (3654-06) January 2017 Version 1.6 Qualification Handbook Qualification at a glance Subject area Health and Safety City & Guilds number 3654 Age
World Federation for Culture Collections ICCC-12 Conference 2010 Florianopolis, Brazil, 26 Sept 1 Oct 2010 The Biosafety and Laboratory Biosecurity programme at the World Health Organization Dr Nicoletta
Guideline: Administrative & Logistic Arrangement in Supporting The Joint Multi-Sectoral Outbreak Investigation & Response in ASEAN I. Introduction Emerging infectious diseases respect no boundaries. Most
State of Palestine Ministry of Health General directorate of Health Policies and Planning National Health Strategy 2017-2022 DRAFT English Summary By Dr. Ola Aker October 2016 National policy agenda Policy
READVERTISED Call for Proposals To Develop and Test Multi-Hazard and Multi- Sectorial National Public Health Emergency Preparedness and Response Plans in Africa Deadline for submission of proposals: 20/04/2018:
POINT OF CARE TESTING (POCT) IN CRITICAL CARE Authors: Dominic Cox Royal Free Hospital London Joan Pearson Leeds General Infirmary In collaboration with ICS standards committee Introduction Point of Care
Content Sheet 11-1: Overview of Norms and Accreditation Role in quality management system Assessment is the means of determining the effectiveness of a laboratory s quality management system. Standards,
Safety Culture in Life Sciences Laboratories: Time for Action Donald R. Callihan Safety Culture in Life Sciences Laboratories: Time for Action Discuss personal and cultural safety ethics that support biorisk
ECDC Fellowship Programme PHT Scientific Guide and Working Manual for EUPHEM For use by fellows, coordinators, and training site supervisors 2015-2016 European Centre for Disease Prevention and Control,
EAST AFRICAN INTERCOUNTRY MEETING ON STRENGTHENING CAPACITY FOR POST-MARKET SURVEILLANCE OF DIAGNOSTICS AND THIRD REGIONAL MEETING OF THE EAST AFRICAN REGIONAL EXTERNAL QUALITY ASSESSMENT SCHEME - EA-REQAS
Government of Afghanistan Health and Nutrition Public Investment Programme Submission for the SY 1383-1385 National Development Budget. Ministry of Health Submitted to MoF January 22, 2004 PIP Health and
African Partnerships for Patient Safety Evaluation Handbook April 2012 WHO/IER/PSP/2012.8 World Health Organization 2012 The designations employed and the presentation of the material in this publication
Meeting the Challenges of Global Laboratory Systems Development: Human Resources Capacity Development Lucy A. Perrone, MSPH, PhD Assistant Professor Department of Global Health, University of Washington
GLOBAL HEALTH SECURITY AGENDA: ACTION PACKAGE PREVENT-3 BIOSAFETY AND BIOSECURITY ASSESSMENT APP3 Working Group An analysis of biosafety and biosecurity scores for the GHSA External Evaluations and WHO
UNION EUROPÉENNE DES MÉDECINS SPÉCIALISTES EUROPEAN UNION OF MEDICAL SPECIALISTS Association internationale sans but lucratif International non-profit organisation Training Requirements for the Specialty
6 th Consultative Stakeholders Meeting on UN PQ of Medicines, Diagnostics and Vaccines 4-5 April, 2011, Geneva, Switzerland Regulatory Control of Diagnostics in Tanzania Hiiti Sillo Ag. Director General
Towards Quality Care for Patients Fast Track to Quality The Six Most Critical Areas for Patient-Centered Care National Department of Health 2011 National Core Standards for Health Establishments in South
Dr. AM Abdullah Inspector General, MOH THE HEALTH SITUATION IN IRAQ 2009 AIMS AND OBJECTIVES The principle objective of the health system is to ensure that the healthcare needs of all Iraqi citizens are
DEMOCRATIC PEOPLE S REPUBLIC OF KOREA Assessment of Capacities using SEA Region Benchmarks for Emergency Preparedness and Response SEA-EHA-22-DEMOCRATIC PEOPLE S REPUBLIC OF KOREA Assessment of Capacities
Medical Laboratories Particular Requirements for Quality and Competence (A New Zealand adoption of ISO 15189:2007) NZS/ISO 15189:2007 Committee Representation Committee P 15189, Medical laboratories Quality
THE CALIFORNIA STATE UNIVERSITY Office of the Chancellor 400 Golden Shore Long Beach, CA 90802-4210 (562) 951-4411 Date: June 20, 2006 Code: HR 2006-15 To: From: CSU Presidents Jackie R. McClain Vice Chancellor
W O R L D H E A L T H REGIONAL OFFICE FOR ORGANIZATION SOUTH - EAST ASIA REGIONAL COMMITTEE Forty-ninth Session Provisional Agenda item SEAIRC49 5 July 996 QUALITY ASSURANCE IN LABORATORY PRACTICES (Working
Guide to Incident Reporting for In-vitro Diagnostic Medical Devices SUR-G0004-4 02 AUGUST 2012 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes
EMERGENCY VEHICLE TECHNICIAN I CERTIFICATION TRAINING STANDARDS Draft 2011 Version 2.15.11 Presentation Draft Emergency Vehicle Technician I... 2 #1: The Role of the Emergency Vehicle Technician I... 2